Financial PerformanceThe company has a net debt to total capital ratio of 0%, indicating a strong financial position.
Product Launch And Market PerformanceStrong launch trajectory for Wainua is expected to continue, driven by its competitive efficacy, at-home self-administration, and capacity to expand the current TTR-PN market.
Regulatory ApprovalsEplontersen received positive CHMP opinion from EMA, and UK approval brought $30mm from AZN.